世界の原発性線毛機能不全市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Primary Ciliary Dyskinesia Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4788
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、原発性線毛機能不全のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子検査、電子顕微鏡）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・原発性線毛機能不全の市場動向
・企業の競争状況、市場シェア
・原発性線毛機能不全の種類別市場規模（遺伝子検査、電子顕微鏡）
・原発性線毛機能不全の用途別市場規模（病院、専門クリニック、その他）
・原発性線毛機能不全の北米市場規模2016-2027（アメリカ、カナダ）
・原発性線毛機能不全のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・原発性線毛機能不全のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・原発性線毛機能不全の中南米市場規模2016-2027（メキシコ、ブラジル）
・原発性線毛機能不全の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Boehringer Ingelheim、Novartis、Teva、Bayer、Rotech Healthcare、Pfizer）
・結論

Primary ciliary dyskinesia (PCD), also called immotile ciliary syndrome or Kartagener syndrome, is a rare, ciliopathic, autosomal recessive genetic disorder that causes defects in the action of cilia lining the respiratory tract (lower and upper, sinuses, Eustachian tube, middle ear), fallopian tube, and flagella of sperm cells.
There no standardized effective treatment strategies for the condition. Severe fatal respiratory failure can develop; long-term treatment with macrolides such as clarithromycin, erythromycin and azithromycin has been empirically applied for the treatment of primary ciliary dyskinesia in Japan, though controversial due to the effects of the medications.

Market Analysis and Insights: Global Primary Ciliary Dyskinesia Market
The global Primary Ciliary Dyskinesia market size is projected to reach US$ 606.1 million by 2026, from US$ 418.8 million in 2019, at a CAGR of 5.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Primary Ciliary Dyskinesia market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Primary Ciliary Dyskinesia market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Primary Ciliary Dyskinesia market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Primary Ciliary Dyskinesia market.

Global Primary Ciliary Dyskinesia Scope and Market Size
Primary Ciliary Dyskinesia market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Primary Ciliary Dyskinesia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Genetic Testing
Electron Microscopy

Segment by Application
Hospitals
Specialty Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Boehringer Ingelheim
Novartis
Teva
Bayer
Rotech Healthcare
Pfizer

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Primary Ciliary Dyskinesia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Genetic Testing
1.2.3 Electron Microscopy
1.3 Market by Application
1.3.1 Global Primary Ciliary Dyskinesia Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Primary Ciliary Dyskinesia Market Perspective (2016-2027)
2.2 Primary Ciliary Dyskinesia Growth Trends by Regions
2.2.1 Primary Ciliary Dyskinesia Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Primary Ciliary Dyskinesia Historic Market Share by Regions (2016-2021)
2.2.3 Primary Ciliary Dyskinesia Forecasted Market Size by Regions (2022-2027)
2.3 Primary Ciliary Dyskinesia Industry Dynamic
2.3.1 Primary Ciliary Dyskinesia Market Trends
2.3.2 Primary Ciliary Dyskinesia Market Drivers
2.3.3 Primary Ciliary Dyskinesia Market Challenges
2.3.4 Primary Ciliary Dyskinesia Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Primary Ciliary Dyskinesia Players by Revenue
3.1.1 Global Top Primary Ciliary Dyskinesia Players by Revenue (2016-2021)
3.1.2 Global Primary Ciliary Dyskinesia Revenue Market Share by Players (2016-2021)
3.2 Global Primary Ciliary Dyskinesia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Primary Ciliary Dyskinesia Revenue
3.4 Global Primary Ciliary Dyskinesia Market Concentration Ratio
3.4.1 Global Primary Ciliary Dyskinesia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Primary Ciliary Dyskinesia Revenue in 2020
3.5 Primary Ciliary Dyskinesia Key Players Head office and Area Served
3.6 Key Players Primary Ciliary Dyskinesia Product Solution and Service
3.7 Date of Enter into Primary Ciliary Dyskinesia Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Primary Ciliary Dyskinesia Breakdown Data by Type
4.1 Global Primary Ciliary Dyskinesia Historic Market Size by Type (2016-2021)
4.2 Global Primary Ciliary Dyskinesia Forecasted Market Size by Type (2022-2027)

5 Primary Ciliary Dyskinesia Breakdown Data by Application
5.1 Global Primary Ciliary Dyskinesia Historic Market Size by Application (2016-2021)
5.2 Global Primary Ciliary Dyskinesia Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Primary Ciliary Dyskinesia Market Size (2016-2027)
6.2 North America Primary Ciliary Dyskinesia Market Size by Type
6.2.1 North America Primary Ciliary Dyskinesia Market Size by Type (2016-2021)
6.2.2 North America Primary Ciliary Dyskinesia Market Size by Type (2022-2027)
6.2.3 North America Primary Ciliary Dyskinesia Market Size by Type (2016-2027)
6.3 North America Primary Ciliary Dyskinesia Market Size by Application
6.3.1 North America Primary Ciliary Dyskinesia Market Size by Application (2016-2021)
6.3.2 North America Primary Ciliary Dyskinesia Market Size by Application (2022-2027)
6.3.3 North America Primary Ciliary Dyskinesia Market Size by Application (2016-2027)
6.4 North America Primary Ciliary Dyskinesia Market Size by Country
6.4.1 North America Primary Ciliary Dyskinesia Market Size by Country (2016-2021)
6.4.2 North America Primary Ciliary Dyskinesia Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Primary Ciliary Dyskinesia Market Size (2016-2027)
7.2 Europe Primary Ciliary Dyskinesia Market Size by Type
7.2.1 Europe Primary Ciliary Dyskinesia Market Size by Type (2016-2021)
7.2.2 Europe Primary Ciliary Dyskinesia Market Size by Type (2022-2027)
7.2.3 Europe Primary Ciliary Dyskinesia Market Size by Type (2016-2027)
7.3 Europe Primary Ciliary Dyskinesia Market Size by Application
7.3.1 Europe Primary Ciliary Dyskinesia Market Size by Application (2016-2021)
7.3.2 Europe Primary Ciliary Dyskinesia Market Size by Application (2022-2027)
7.3.3 Europe Primary Ciliary Dyskinesia Market Size by Application (2016-2027)
7.4 Europe Primary Ciliary Dyskinesia Market Size by Country
7.4.1 Europe Primary Ciliary Dyskinesia Market Size by Country (2016-2021)
7.4.2 Europe Primary Ciliary Dyskinesia Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Primary Ciliary Dyskinesia Market Size (2016-2027)
8.2 Asia-Pacific Primary Ciliary Dyskinesia Market Size by Type
8.2.1 Asia-Pacific Primary Ciliary Dyskinesia Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Primary Ciliary Dyskinesia Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Primary Ciliary Dyskinesia Market Size by Type (2016-2027)
8.3 Asia-Pacific Primary Ciliary Dyskinesia Market Size by Application
8.3.1 Asia-Pacific Primary Ciliary Dyskinesia Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Primary Ciliary Dyskinesia Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Primary Ciliary Dyskinesia Market Size by Application (2016-2027)
8.4 Asia-Pacific Primary Ciliary Dyskinesia Market Size by Region
8.4.1 Asia-Pacific Primary Ciliary Dyskinesia Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Primary Ciliary Dyskinesia Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Primary Ciliary Dyskinesia Market Size (2016-2027)
9.2 Latin America Primary Ciliary Dyskinesia Market Size by Type
9.2.1 Latin America Primary Ciliary Dyskinesia Market Size by Type (2016-2021)
9.2.2 Latin America Primary Ciliary Dyskinesia Market Size by Type (2022-2027)
9.2.3 Latin America Primary Ciliary Dyskinesia Market Size by Type (2016-2027)
9.3 Latin America Primary Ciliary Dyskinesia Market Size by Application
9.3.1 Latin America Primary Ciliary Dyskinesia Market Size by Application (2016-2021)
9.3.2 Latin America Primary Ciliary Dyskinesia Market Size by Application (2022-2027)
9.3.3 Latin America Primary Ciliary Dyskinesia Market Size by Application (2016-2027)
9.4 Latin America Primary Ciliary Dyskinesia Market Size by Country
9.4.1 Latin America Primary Ciliary Dyskinesia Market Size by Country (2016-2021)
9.4.2 Latin America Primary Ciliary Dyskinesia Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Primary Ciliary Dyskinesia Market Size (2016-2027)
10.2 Middle East & Africa Primary Ciliary Dyskinesia Market Size by Type
10.2.1 Middle East & Africa Primary Ciliary Dyskinesia Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Primary Ciliary Dyskinesia Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Primary Ciliary Dyskinesia Market Size by Type (2016-2027)
10.3 Middle East & Africa Primary Ciliary Dyskinesia Market Size by Application
10.3.1 Middle East & Africa Primary Ciliary Dyskinesia Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Primary Ciliary Dyskinesia Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Primary Ciliary Dyskinesia Market Size by Application (2016-2027)
10.4 Middle East & Africa Primary Ciliary Dyskinesia Market Size by Country
10.4.1 Middle East & Africa Primary Ciliary Dyskinesia Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Primary Ciliary Dyskinesia Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Primary Ciliary Dyskinesia Introduction
11.1.4 Boehringer Ingelheim Revenue in Primary Ciliary Dyskinesia Business (2016-2021)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Primary Ciliary Dyskinesia Introduction
11.2.4 Novartis Revenue in Primary Ciliary Dyskinesia Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Primary Ciliary Dyskinesia Introduction
11.3.4 Teva Revenue in Primary Ciliary Dyskinesia Business (2016-2021)
11.3.5 Teva Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Primary Ciliary Dyskinesia Introduction
11.4.4 Bayer Revenue in Primary Ciliary Dyskinesia Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Rotech Healthcare
11.5.1 Rotech Healthcare Company Details
11.5.2 Rotech Healthcare Business Overview
11.5.3 Rotech Healthcare Primary Ciliary Dyskinesia Introduction
11.5.4 Rotech Healthcare Revenue in Primary Ciliary Dyskinesia Business (2016-2021)
11.5.5 Rotech Healthcare Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Primary Ciliary Dyskinesia Introduction
11.6.4 Pfizer Revenue in Primary Ciliary Dyskinesia Business (2016-2021)
11.6.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Primary Ciliary Dyskinesia Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Genetic Testing
Table 3. Key Players of Electron Microscopy
Table 4. Global Primary Ciliary Dyskinesia Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Primary Ciliary Dyskinesia Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Primary Ciliary Dyskinesia Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Primary Ciliary Dyskinesia Market Share by Regions (2016-2021)
Table 8. Global Primary Ciliary Dyskinesia Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Primary Ciliary Dyskinesia Market Share by Regions (2022-2027)
Table 10. Primary Ciliary Dyskinesia Market Trends
Table 11. Primary Ciliary Dyskinesia Market Drivers
Table 12. Primary Ciliary Dyskinesia Market Challenges
Table 13. Primary Ciliary Dyskinesia Market Restraints
Table 14. Global Primary Ciliary Dyskinesia Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Primary Ciliary Dyskinesia Market Share by Players (2016-2021)
Table 16. Global Top Primary Ciliary Dyskinesia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Primary Ciliary Dyskinesia as of 2020)
Table 17. Ranking of Global Top Primary Ciliary Dyskinesia Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Primary Ciliary Dyskinesia Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Primary Ciliary Dyskinesia Product Solution and Service
Table 21. Date of Enter into Primary Ciliary Dyskinesia Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Primary Ciliary Dyskinesia Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Primary Ciliary Dyskinesia Revenue Market Share by Type (2016-2021)
Table 25. Global Primary Ciliary Dyskinesia Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Primary Ciliary Dyskinesia Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Primary Ciliary Dyskinesia Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Primary Ciliary Dyskinesia Revenue Market Share by Application (2016-2021)
Table 29. Global Primary Ciliary Dyskinesia Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Primary Ciliary Dyskinesia Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Primary Ciliary Dyskinesia Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Primary Ciliary Dyskinesia Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Primary Ciliary Dyskinesia Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Primary Ciliary Dyskinesia Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Primary Ciliary Dyskinesia Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Primary Ciliary Dyskinesia Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Primary Ciliary Dyskinesia Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Primary Ciliary Dyskinesia Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Primary Ciliary Dyskinesia Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Primary Ciliary Dyskinesia Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Primary Ciliary Dyskinesia Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Primary Ciliary Dyskinesia Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Primary Ciliary Dyskinesia Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Primary Ciliary Dyskinesia Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Primary Ciliary Dyskinesia Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Primary Ciliary Dyskinesia Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Primary Ciliary Dyskinesia Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Primary Ciliary Dyskinesia Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Primary Ciliary Dyskinesia Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Primary Ciliary Dyskinesia Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Primary Ciliary Dyskinesia Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Primary Ciliary Dyskinesia Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Primary Ciliary Dyskinesia Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Primary Ciliary Dyskinesia Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Primary Ciliary Dyskinesia Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Primary Ciliary Dyskinesia Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Primary Ciliary Dyskinesia Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Primary Ciliary Dyskinesia Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Primary Ciliary Dyskinesia Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Primary Ciliary Dyskinesia Market Size by Country (2022-2027) & (US$ Million)
Table 61. Boehringer Ingelheim Company Details
Table 62. Boehringer Ingelheim Business Overview
Table 63. Boehringer Ingelheim Primary Ciliary Dyskinesia Product
Table 64. Boehringer Ingelheim Revenue in Primary Ciliary Dyskinesia Business (2016-2021) & (US$ Million)
Table 65. Boehringer Ingelheim Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Primary Ciliary Dyskinesia Product
Table 69. Novartis Revenue in Primary Ciliary Dyskinesia Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Primary Ciliary Dyskinesia Product
Table 74. Teva Revenue in Primary Ciliary Dyskinesia Business (2016-2021) & (US$ Million)
Table 75. Teva Recent Development
Table 76. Bayer Company Details
Table 77. Bayer Business Overview
Table 78. Bayer Primary Ciliary Dyskinesia Product
Table 79. Bayer Revenue in Primary Ciliary Dyskinesia Business (2016-2021) & (US$ Million)
Table 80. Bayer Recent Development
Table 81. Rotech Healthcare Company Details
Table 82. Rotech Healthcare Business Overview
Table 83. Rotech Healthcare Primary Ciliary Dyskinesia Product
Table 84. Rotech Healthcare Revenue in Primary Ciliary Dyskinesia Business (2016-2021) & (US$ Million)
Table 85. Rotech Healthcare Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Primary Ciliary Dyskinesia Product
Table 89. Pfizer Revenue in Primary Ciliary Dyskinesia Business (2016-2021) & (US$ Million)
Table 90. Pfizer Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Primary Ciliary Dyskinesia Market Share by Type: 2020 VS 2027
Figure 2. Genetic Testing Features
Figure 3. Electron Microscopy Features
Figure 4. Global Primary Ciliary Dyskinesia Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Specialty Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Primary Ciliary Dyskinesia Report Years Considered
Figure 9. Global Primary Ciliary Dyskinesia Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Primary Ciliary Dyskinesia Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Primary Ciliary Dyskinesia Market Share by Regions: 2020 VS 2027
Figure 12. Global Primary Ciliary Dyskinesia Market Share by Regions (2022-2027)
Figure 13. Global Primary Ciliary Dyskinesia Market Share by Players in 2020
Figure 14. Global Top Primary Ciliary Dyskinesia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Primary Ciliary Dyskinesia as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Primary Ciliary Dyskinesia Revenue in 2020
Figure 16. Global Primary Ciliary Dyskinesia Revenue Market Share by Type (2016-2021)
Figure 17. Global Primary Ciliary Dyskinesia Revenue Market Share by Type (2022-2027)
Figure 18. North America Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Primary Ciliary Dyskinesia Market Share by Type (2016-2027)
Figure 20. North America Primary Ciliary Dyskinesia Market Share by Application (2016-2027)
Figure 21. North America Primary Ciliary Dyskinesia Market Share by Country (2016-2027)
Figure 22. United States Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Primary Ciliary Dyskinesia Market Share by Type (2016-2027)
Figure 26. Europe Primary Ciliary Dyskinesia Market Share by Application (2016-2027)
Figure 27. Europe Primary Ciliary Dyskinesia Market Share by Country (2016-2027)
Figure 28. Germany Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Primary Ciliary Dyskinesia Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Primary Ciliary Dyskinesia Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Primary Ciliary Dyskinesia Market Share by Region (2016-2027)
Figure 38. China Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Primary Ciliary Dyskinesia Market Share by Type (2016-2027)
Figure 46. Latin America Primary Ciliary Dyskinesia Market Share by Application (2016-2027)
Figure 47. Latin America Primary Ciliary Dyskinesia Market Share by Country (2016-2027)
Figure 48. Mexico Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Primary Ciliary Dyskinesia Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Primary Ciliary Dyskinesia Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Primary Ciliary Dyskinesia Market Share by Country (2016-2027)
Figure 54. Turkey Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Primary Ciliary Dyskinesia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Primary Ciliary Dyskinesia Business (2016-2021)
Figure 58. Novartis Revenue Growth Rate in Primary Ciliary Dyskinesia Business (2016-2021)
Figure 59. Teva Revenue Growth Rate in Primary Ciliary Dyskinesia Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in Primary Ciliary Dyskinesia Business (2016-2021)
Figure 61. Rotech Healthcare Revenue Growth Rate in Primary Ciliary Dyskinesia Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Primary Ciliary Dyskinesia Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

以下、関連資料のご紹介

世界の遅発性ジスキネジア市場規模・現状・予測（2021年-2027年）

Global Tardive Dyskinesia Market Size, Status and Forecast 2021-2027
QYR2104Z5551 2021年4月 99Pages
QYResearch社発行の本調査資料では、遅発性ジスキネジアのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ドーパミン枯渇薬、GABA受容体アゴニスト薬、抗コリン薬）、用途別市場規模（病院、外来手術センター、診断センター）、主要地域別市場規模...

世界の遅発性ジスキネジア（TD）治療市場規模・現状・予測（2021年-2027年）

Global Tardive Dyskinesia (TD) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5550 2021年4月 90Pages
QYResearch社発行の本調査資料では、遅発性ジスキネジア（TD）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（バルベナジン、アマンタジン、テトラベナジン、クロナゼパム、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場...

世界の遅発性ジスキネジア（TD）治療市場規模・現状・予測（2021年-2027年）

世界の原発性アルドステロン症市場規模・現状・予測（2021年-2027年）

Global Primary Aldosteronism Market Size, Status and Forecast 2021-2027
QYR2104Z4786 2021年4月 96Pages
QYResearch社発行の本調査資料では、原発性アルドステロン症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血液検査、画像検査）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の原発性免疫不全症治療市場規模・現状・予測（2021年-2027年）

Global Primary Immunodeficiency Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4789 2021年4月 95Pages
QYResearch社発行の本調査資料では、原発性免疫不全症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫グロブリン療法、抗生物質、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の一次進行性多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Primary Progressive Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4790 2021年4月 94Pages
QYResearch社発行の本調査資料では、一次進行性多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ApE、ビオチン、GZ-402668、イブジラスト、イデベノン、ラキニモドナトリウム、その他）、用途別市場規模（病院、診療所、...

世界の遅発性ジスキネジア（TD）治療市場 2021：企業別、地域別、種類・用途別

Global Tardive Dyskinesia (TD) Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z13625 2021年4月 108Pages
当調査資料では、遅発性ジスキネジア（TD）治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遅発性ジスキネジア（TD）治療の種類別市場規模（バルベナジン、アマンタジン、テトラベナジン、クロナゼパム、その他）、用途別市場規模（病院、診療所、その他）、地...

世界の一次フレキシブル電池市場 2021：企業別、地域別、種類・用途別

Global Primary Flexible Battery Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z11487 2021年4月 105Pages
当調査資料では、一次フレキシブル電池のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。一次フレキシブル電池の種類別市場規模（Li-MnO2電池、炭素亜鉛電池、リチウムイオン電池）、用途別市場規模（スマートセキュリティ・ペイメントカード、ノベルティパッケー...

世界のナルコレプシー治療市場規模・現状・予測（2021年-2027年）

Global Narcolepsy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4022 2021年4月 94Pages
QYResearch社発行の本調査資料では、ナルコレプシー治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他）、用途別市場規模（脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発...

世界の股関節再建市場規模・現状・予測（2021年-2027年）

Global Hip Reconstruction Market Size, Status and Forecast 2021-2027
QYR2104Z2848 2021年4月 93Pages
QYResearch社発行の本調査資料では、股関節再建のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プライマリセメント股関節置換術、プライマリセメントレス股関節置換術、部分股関節置換術、改訂股関節置換術、股関節リサーフェシング）、用途別市場規...

世界の遅発性ジスキネジア市場規模・現状・予測（2021年-2027年） Tardive Dyskinesia (TD) market is estimated to post significant growth in coming years, owing to rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription and increasing incidence of neurological disorders. The key factors driving the growth of the Tardive dyskin…
世界の遅発性ジスキネジア（TD）治療市場規模・現状・予測（2021年-2027年） Tardive dyskinesia (TD) is a neurological disorder that has the involvement of the involuntary movements. The terms can be described as tardive which means delayed and dyskinesia which means abnormal movement. The symptoms of tardive dyskinesia include finger movement, facial grimacing, jaw swinging…
世界の遅発性ジスキネジア（TD）治療市場規模・現状・予測（2021年-2027年） Tardive dyskinesia (TD) is a neurological disorder that has the involvement of the involuntary movements. The terms can be described as tardive which means delayed and dyskinesia which means abnormal movement. The symptoms of tardive dyskinesia include finger movement, facial grimacing, jaw swinging…
世界の遅発性ジスキネジア（TD）治療市場 2021：企業別、地域別、種類・用途別 The Tardive Dyskinesia (TD) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
世界の原発性アルドステロン症市場規模・現状・予測（2021年-2027年） Primary aldosteronism refers to the excess production of the hormone aldosterone from the adrenal glands, resulting in low renin levels. This abnormality is caused by hyperplasia or tumors. Many suffer from fatigue, potassium deficiency and high blood pressure which may cause poor vision, confusion …